| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
The Cover
The effect of bryostatin and GM-CSF on leukemic blasts from a patient with M1 AML. Although neither agent alone had much of an effect, the combination induced morphological evidence of myeloid differentiation with a decrease in the nuclear-cytoplasmic ratio, nuclear condensation with the loss of nucleoli, and the appearance of cytoplasmic granulation and vacuoles combination. For datails, see the article by Matsui et al., in this issue.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |